FIH, Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, Atopic Dermatitis, Chronic Rhinosinusitis, Nasal Polyps
Showing 1 - 25 of >10,000
Healthy, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis Trial in United States (PF-06817024, Placebo for
Completed
- Healthy
- +2 more
- PF-06817024
- Placebo for PF-06817024
-
Sacramento, California
- +19 more
Feb 28, 2022
Chronic Rhinosinusitis With Nasal Polyps Trial (TRL1068)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- (no location specified)
Oct 20, 2022
Chronic Rhinosinusitis Trial (Airiver Nasal Drug Coated Balloon (DCB) Catheter.)
Not yet recruiting
- Chronic Rhinosinusitis
- Airiver Nasal Drug Coated Balloon (DCB) Catheter.
- (no location specified)
May 30, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial in Beijing (GR1802 injection, )
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- GR1802 injection
- placebo
-
Beijing, Beijing, ChinaBeijing Tongren Hospital
May 16, 2023
Chronic Rhinosinusitis With Nasal Polyposis Trial (CM310, Placebo)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyposis
- CM310
- Placebo
- (no location specified)
Jun 30, 2022
Hidradenitis Suppurativa, Atopic Dermatitis, Healthy Volunteer Trial (LT-002-158/Placebo oral tablet(s))
Not yet recruiting
- Hidradenitis Suppurativa
- +2 more
- LT-002-158/Placebo oral tablet(s)
- (no location specified)
Oct 9, 2023
Chronic Rhinosinusitis (Diagnosis), Nasal Polyps Trial in China (CM310, Placebo)
Completed
- Chronic Rhinosinusitis (Diagnosis)
- Nasal Polyps
- CM310
- Placebo
-
Beijing, Beijing, China
- +18 more
Jun 23, 2022
IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With
Not yet recruiting
- Chronic Rhino-sinusitis
- +3 more
- IL-4R
- Placebo
-
Beijing, Beijing, ChinaBeijing Tongren Hospital, Capital Medical University
Jun 17, 2022
Chronic Sinusitis, Nasal Polyps Trial in China (TQC2731 injection, TQC2731 matching )
Not yet recruiting
- Chronic Sinusitis
- Nasal Polyps
- TQC2731 injection
- TQC2731 matching placebo
-
Wuhu, Anhui, China
- +15 more
Sep 12, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial (GR1802 injection)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- GR1802 injection
- (no location specified)
Aug 22, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial in Kafrelsheikh (Budesonide, Prednisone, Saline)
Completed
- Chronic Rhinosinusitis With Nasal Polyps
- Budesonide
- +2 more
-
Kafrelsheikh, EgyptKafrelsheikh University hospital
Jul 3, 2023
Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- +2 more
- Mepolizumab 100 MG
-
Athens, Attiki, Greece
- +1 more
Sep 29, 2023
Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Xolair
-
Bundang Gu, Gyeonggi Do, Korea, Republic ofNovartis Investigative Site
Jan 19, 2023
Atopic Dermatitis, Healthy Volunteers Trial (Tezepelumab, Placebo)
Completed
- Atopic Dermatitis
- Healthy Volunteers
- Tezepelumab
- Placebo
- (no location specified)
Sep 8, 2022
Chronic Rhinosinusitis With Nasal Polyps Trial (SHR-1905 Injection, SHR-1905 Placebo Injection)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- SHR-1905 Injection
- SHR-1905 Placebo Injection
- (no location specified)
Jun 4, 2023
Chronic Rhinosinusitis With Nasal Polyps, Glucocorticoids Trial in Beijing (Oral Glucocorticoids)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Glucocorticoids
- Oral Glucocorticoids
-
Beijing, Beijing, ChinaBeijing Tongren Hospital, Capital Medical University
Oct 25, 2022
Sinusitis Trial in China (300mg of TQH2722 injection, 600mg of TQH2722 injection, TQH2722 injection matching )
Not yet recruiting
- Sinusitis
- 300mg of TQH2722 injection
- +2 more
-
Wuhu, Anhui, China
- +26 more
Oct 17, 2023
Allergic Fungal Rhinosinusitis Trial in Atlanta, Nashville, Houston (Dupilumab 300 MG/2 ML Subcutaneous Solution, Placebo)
Not yet recruiting
- Allergic Fungal Rhinosinusitis
- Dupilumab 300 MG/2 ML Subcutaneous Solution
- Placebo
-
Atlanta, Georgia
- +3 more
Nov 16, 2022
Moderate-to-severe Atopic Dermatitis Trial in Beijing (CM326, Placebo)
Recruiting
- Moderate-to-severe Atopic Dermatitis
- CM326
- Placebo
-
Beijing, ChinaPeking University People's hospital
Dec 31, 2022
Chronic Rhinosinusitis With Nasal Polyps, Asthma, Chronic Rhinosinusitis Without Nasal Polyps Trial (Mepolizumab, Placebo)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- +2 more
- Mepolizumab
- Placebo
- (no location specified)
Nov 29, 2022
Chronic Rhinosinusitis With Nasal Polyps, Glucocorticoids Trial in Beijing (Oral Glucocorticoids, Oral )
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Glucocorticoids
- Oral Glucocorticoids
- Oral placebo
-
Beijing, Beijing, ChinaBeijing Tongren Hospital, Capital Medical University
Oct 25, 2022